| Gene Name: |
TNFRSF13B |
| Species Reactivity: |
Mouse (Mus musculus) |
| Synonyms: |
TACI CD267 IGAD2 |
| Uniprot: |
Q9ET35 |
| Description: |
this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against |
| Storage and handling: |
Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| Gene target: |
TNFRSF13B |
| Short name: |
Anti-Mouse TNFRSF13B |
| Technique: |
mouses, Mouse |
| Species: |
Mouses, Mouse |
| Alternative name: |
member 13B, antibody to-Mouse tumor necrosis factor receptor superfamily |
| Alternative technique: |
murine |
| Alternative to gene target: |
CD267 and CVID and CVID2 and RYZN and TACI and TNFRSF14B, Cell surfaces, TNFRSF13B and IDBG-408940 and ENSG00000240505 and 23495, TNFRSF13B and IDBG-638376 and ENSBTAG00000015298 and, Tnfrsf13b and IDBG-182161 and ENSMUSG00000010142 and 57916, member 13B, protein binding, this GO :0001782 and B cell homeostasis and biological process this GO :0002244 and hematopoietic progenitor cell differentiation and biological process this GO :0004872 and receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0030889 and negative regulation of B cell proliferation and biological process, this GO :0004872 : receptor activity, this GO :0004872 : receptor activity and also this GO :0005515 : protein binding, this GO :0005515 : protein binding, tumor necrosis factor receptor superfamily |
| Identity: |
18153 |
| Gene: |
TNFRSF13B |
More about : TNFRSF13B |
| Long gene name: |
TNF receptor superfamily member 13B |
| Synonyms gene name: |
member 13B , tumor necrosis factor receptor superfamily |
| Locus: |
17p11, 2 |
| Discovery year: |
2002-05-22 |
| GenBank acession: |
AF023614 |
| Entrez gene record: |
23495 |
| Pubmed identfication: |
9311921 |
| Classification: |
CD molecules Tumor necrosis factor receptor superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000059262 |
| Locus Specific Databases: |
TNFRSF13Bbase: Mutation registry for TACI deficiency LRG_120 |